MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients
Clinical trial NCT06044493 · COMPLETED
Trial details
- NCT number
- NCT06044493
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-14
- Primary completion
- 2025-10-29
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.